Comparative Effectiveness of a Breath-Operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

This study has been completed.

Sponsored by:	IVAX Research LLC
Information provided by:	IVAX Research LLC
ClinicalTrials.gov Identifier:	NCT00054964

Purpose

This study is designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.

Condition	Intervention	Phase
Asthma	Drug: Albuterol	Phase II

MedlinePlus related topics: Asthma

Drug Information available for: Albuterol sulfate Albuterol Levalbuterol hydrochloride Levalbuterol tartrate

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Further study details as provided by IVAX Research LLC:

Study Start Date:

March 2003

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Stable asthma
Poor inhaler coordination technique.

Exclusion Criteria:

Requires beta-blockers, MAO inhibitors, tricyclic antidepressants, long-acting beta-blockers, steroids other than those inhaled

Contacts and Locations

No Contacts or Locations Provided

More Information

Study ID Numbers:	IXR-202-4-167
Study First Received:	February 14, 2003
Last Updated:	May 6, 2008
ClinicalTrials.gov Identifier:	NCT00054964
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases

Albuterol
Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:

Respiratory System Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Bronchial Diseases
Immune System Diseases
Adrenergic beta-Agonists
Physiological Effects of Drugs
Anti-Asthmatic Agents

Reproductive Control Agents
Adrenergic Agonists
Pharmacologic Actions
Tocolytic Agents
Autonomic Agents
Therapeutic Uses
Peripheral Nervous System Agents
Bronchodilator Agents

ClinicalTrials.gov processed this record on January 14, 2009